Published • loading... • Updated
Could a Blood Test Predict Risk of Brain Swelling During Alzheimer’s Treatment?
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Could a Blood Test Predict Risk of Brain Swelling During Alzheimer’s Treatment?
Researchers found a five-marker panel that distinguished cerebral amyloid angiopathy, a major driver of brain swelling and bleeding associated with anti-amyloid therapies. Researchers at Banner Sun Health Research Institute have identified a blood-based biomarker panel that may identify Alzheimer’s disease patients at increased risk for brain swelling or bleeding associated with new anti-amyloid therapies. The study, published in Acta Neuropatho…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
